Last 11 quarters of trend data · Technology · Semiconductors
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Astera Labs, Inc. Common Stock's quarterly P/E stands at 62.3x, down 24.9% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 64.6% YoY to 75.2x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 325.43 | 62.27 | 166.36 | 97.90 | 77.95 | 82.88 | 236.52 | — | — | — | — | — |
| — | -24.9% | -29.7% | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 79.27 | 16.10 | 27.85 | 38.35 | 20.98 | 16.66 | 41.67 | 18.16 | 30.55 | 43.73 | — | — |
| — | -3.4% | -33.2% | +111.1% | -31.3% | -61.9% | — | — | — | — | — | — | |
| P/B Ratio | 52.28 | 13.29 | 22.10 | 27.81 | 14.18 | 10.20 | 24.38 | 9.24 | 11.11 | 14.11 | — | — |
| — | +30.2% | -9.3% | +201.1% | +27.6% | -27.7% | — | — | — | — | — | — | |
| P/FCF | 239.84 | 74.07 | 98.40 | 134.22 | 30.19 | 445.44 | 242.40 | 43.88 | 75.40 | 12515.58 | — | — |
| — | -83.4% | -59.4% | +205.9% | -60.0% | -96.4% | — | — | — | — | — | — | |
| EV / EBITDA | 374.18 | 75.17 | 107.48 | 155.02 | 96.81 | 212.36 | 5241.37 | — | — | — | — | — |
| — | -64.6% | -97.9% | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 388.91 | 79.68 | 95.07 | 131.93 | 100.20 | 233.53 | 40693.45 | — | — | — | — | — |
| — | -65.9% | -99.8% | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Astera Labs, Inc. Common Stock's operating margin was 20.1% in Q1 2026, down 4.7 pp QoQ and up 13.0 pp YoY. The trailing four-quarter average of 22.4% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.7% | 76.3% | 75.6% | 76.2% | 75.8% | 74.9% | 74.0% | 77.7% | 77.9% | 77.4% | 77.3% | 24.1% |
| — | +1.8% | +2.1% | -1.9% | -2.6% | -3.3% | -4.2% | +222.4% | — | — | — | — | |
| Operating Margin | 20.3% | 20.1% | 24.7% | 24.0% | 20.7% | 7.1% | 0.1% | -7.9% | -31.7% | -127.1% | 17.9% | -107.2% |
| — | +183.3% | +24136.8% | +405.5% | +165.4% | +105.6% | -99.4% | +92.7% | — | — | — | — | |
| Net Margin | 25.7% | 26.0% | 16.6% | 39.5% | 26.7% | 20.0% | 17.5% | -6.7% | -9.8% | -142.5% | 28.4% | -98.8% |
| — | +30.5% | -5.1% | +688.5% | +371.8% | +114.0% | -38.2% | +93.2% | — | — | — | — |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 18.8% | 5.6% | 3.4% | 7.6% | 4.7% | 3.2% | 2.7% | -0.9% | -0.9% | -26.2% | — | -10.3% |
| — | +77.2% | +28.1% | +964.8% | +615.7% | +112.1% | — | +91.5% | — | — | — | — | |
| ROA | 16.9% | 5.0% | 3.1% | 6.8% | 4.3% | 2.9% | 2.4% | -0.8% | -0.8% | -17.5% | 7.3% | — |
| — | +72.1% | +26.5% | +952.4% | +605.0% | +116.7% | -66.8% | — | — | — | — | — | |
| ROIC | 12.3% | 3.6% | 4.1% | 3.8% | 3.1% | 0.9% | 0.0% | -1.1% | -6.7% | -54.1% | — | -8.4% |
| — | +291.6% | +31572.5% | +442.6% | +145.9% | +101.7% | — | +86.6% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 18.8% YoY to 11.30x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | — | 0.03 | 0.05 | — | — | 0.00 | — | 0.00 | 0.00 | — | — |
| — | — | +1833.6% | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 0.19 | — | 0.50 | 1.02 | — | — | 1.15 | — | — | — | 0.23 | — |
| — | — | -56.2% | — | — | — | +410.0% | — | — | — | — | — | |
| Current Ratio | 10.24 | 11.30 | 10.24 | 12.78 | 11.10 | 13.92 | 11.71 | 10.74 | 13.91 | 18.74 | 5.30 | — |
| — | -18.8% | -12.5% | +19.0% | -20.2% | -25.7% | +121.0% | — | — | — | — | — | |
| Quick Ratio | 9.79 | 10.82 | 9.79 | 12.27 | 10.55 | 13.26 | 11.21 | 10.46 | 13.46 | 18.09 | 4.61 | — |
| — | -18.4% | -12.6% | +17.2% | -21.7% | -26.7% | +143.1% | — | — | — | — | — | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 11 years · Updated daily
Deep dive into ALAB consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALAB stock.
Astera Labs, Inc. Common Stock's current P/E is 325.4x. The average P/E over the last 4 quarters is 101.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Astera Labs, Inc. Common Stock's current operating margin is 20.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Astera Labs, Inc. Common Stock's business trajectory between earnings reports.